PDS Biotechnology Corp — Director's Dealing 2020

Mar 25, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: PDS Biotechnology Corp (PDSB)
CIK: 0001472091
Period of Report: 2020-03-23

Reporting Person: Trochimiuk Janetta (N/A)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$2.88	2029-12-09	Common Stock (10000)		Direct

Footnotes

F1: The option was granted on December 9, 2019, with 25% vesting on December 9, 2020 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.